Migraine is the second most disabling neurological condition in the world, according to the Global Burden of Disease study, and the headache specialty clinics treating it manage one of the most complex prior authorization environments in outpatient neurology. The approval of CGRP monoclonal antibodies — erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and eptinezumab (Vyepti) — and onabotulinumtoxinA (Botox) for chronic migraine requires documentation of migraine frequency, diagnostic adherence to ICHD-3 criteria, and failure of typically two to four prior preventive medications.
Virtual assistants trained in headache specialty workflows are managing these authorization cycles while also supporting the clinical operations of busy migraine practices.
CGRP Therapy Prior Authorization Management
CGRP monoclonal antibodies transformed migraine prevention when they launched in 2018, but their prior authorization requirements remain burdensome. Payers typically require documentation of four or more migraine days per month, failure of at least two to three oral preventive medications from different drug classes (typically a beta blocker, tricyclic antidepressant, topiramate, or valproate), and a physician attestation of chronic migraine diagnosis meeting ICHD-3 criteria.
Virtual assistants manage CGRP prior authorization by pulling migraine frequency data from the patient's chart or headache diary, compiling prior preventive medication failure documentation, submitting the payer authorization request with a structured clinical narrative, tracking approval status, and escalating denied requests for physician peer-to-peer review. For patients with step therapy requirements, VAs track the step therapy compliance timeline to determine when the patient qualifies for CGRP approval.
According to the American Headache Society's 2024 state of migraine care survey, 67% of headache specialists reported that prior authorization for CGRP therapies was the most time-consuming administrative task in their practice — a problem that specialized VA support directly addresses.
OnabotulinumtoxinA (Botox) Injection Scheduling
OnabotulinumtoxinA injections for chronic migraine (PREEMPT protocol, 31 injection sites, every 12 weeks) are both a clinical procedure and a scheduling management challenge. Each injection series requires prior authorization renewal, physician availability, procedure room access, and careful timing to maintain the 12-week interval that payers require to authorize the next series.
Virtual assistants manage Botox injection scheduling by tracking each patient's injection series calendar, initiating the prior authorization renewal 30 days before the authorization expiration date, scheduling the procedure appointment with the appropriate provider, sending patient appointment reminders with preparation instructions, and documenting the injection procedure in the EHR with the correct CPT code (64615) and units. For practices with multiple providers administering Botox, VAs maintain a unified injection calendar to prevent scheduling conflicts.
Headache Diary Data Collection
Patient-reported headache frequency and severity data is essential for CGRP and Botox authorization renewals, clinical outcome assessment, and treatment adjustments. Traditional paper headache diaries are often incomplete or not returned — digital diary tools sent through the patient portal or via SMS improve completion rates but still require administrative follow-up.
Virtual assistants coordinate headache diary data collection by sending digital diary forms to patients between visits, following up with patients who have not submitted diary entries, compiling diary data into a structured report for the treating neurologist's review before each visit, and flagging patients whose headache frequency data suggests a need for treatment escalation. This data collection function ensures that CGRP authorization renewals are supported by current, patient-reported outcome data rather than recalled estimates.
Neuroimaging Coordination
Many patients presenting to headache clinics require MRI or CT brain imaging to rule out secondary headache causes. These studies require prior authorization from commercial payers, referral coordination with a neuroimaging center, and results routing back to the headache specialist with appropriate documentation.
Virtual assistants handle neuroimaging coordination by submitting prior authorization requests with supporting headache history documentation, scheduling the imaging study with an appropriate facility, sending patient preparation instructions, and routing completed imaging reports back to the headache specialist for review and documentation. For patients with contrast MRI requirements or gadolinium concerns, VAs confirm the specific imaging protocol with the ordering physician before scheduling.
Building Efficient Migraine Practice Administration
The administrative demands of CGRP management, Botox injection coordination, and outcomes documentation place a significant burden on headache specialty practices already stretched by patient demand. Virtual assistants provide specialized support that allows headache specialists to see more patients with greater confidence in the completeness of their authorization and documentation workflows. Visit Stealth Agents to explore virtual assistant services purpose-built for headache and migraine specialty practices.
Sources
- American Headache Society (AHS), State of Migraine Care Survey, 2024
- Global Burden of Disease Collaborators, Neurological Disorders Disability Rankings, 2023
- International Classification of Headache Disorders (ICHD-3), IHS Guidelines, 2024